|Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors|
B Routy, E Le Chatelier, L Derosa, CPM Duong, MT Alou, R Daillère, ...
Science 359 (6371), 91-97, 2018
|Structure and degradation of circular RNAs regulate PKR activation in innate immunity|
CX Liu, X Li, F Nan, S Jiang, X Gao, SK Guo, W Xue, Y Cui, K Dong, ...
Cell 177 (4), 865-880. e21, 2019
|MicroRNA‐125a contributes to elevated inflammatory chemokine RANTES levels via targeting KLF13 in systemic lupus erythematosus|
X Zhao, Y Tang, B Qu, H Cui, S Wang, L Wang, X Luo, X Huang, J Li, ...
Arthritis & Rheumatism 62 (11), 3425-3435, 2010
|Identification of the long noncoding RNA NEAT1 as a novel inflammatory regulator acting through MAPK pathway in human lupus|
F Zhang, L Wu, J Qian, B Qu, S Xia, T La, Y Wu, J Ma, J Zeng, Q Guo, ...
Journal of autoimmunity 75, 96-104, 2016
|Interferon‐α priming promotes lipid uptake and macrophage‐derived foam cell formation: a novel link between interferon‐α and atherosclerosis in lupus|
J Li, Q Fu, H Cui, B Qu, W Pan, N Shen, C Bao
Arthritis & Rheumatism 63 (2), 492-502, 2011
|Type I Interferon Inhibition of MicroRNA‐146a Maturation Through Up‐Regulation of Monocyte Chemotactic Protein–Induced Protein 1 in Systemic Lupus Erythematosus|
B Qu, J Cao, F Zhang, H Cui, J Teng, J Li, Z Liu, C Morehouse, B Jallal, ...
Arthritis & Rheumatology 67 (12), 3209-3218, 2015
|Identification of microRNA‐31 as a novel regulator contributing to impaired interleukin‐2 production in T cells from patients with systemic lupus erythematosus|
W Fan, D Liang, Y Tang, B Qu, H Cui, X Luo, X Huang, S Chen, BW Higgs, ...
Arthritis & Rheumatism 64 (11), 3715-3725, 2012
|Association of large intergenic noncoding RNA expression with disease activity and organ damage in systemic lupus erythematosus|
Y Wu, F Zhang, J Ma, X Zhang, L Wu, B Qu, S Xia, S Chen, Y Tang, ...
Arthritis research & therapy 17 (1), 1-11, 2015
|SENP7 potentiates cGAS activation by relieving SUMO-mediated inhibition of cytosolic DNA sensing|
Y Cui, H Yu, X Zheng, R Peng, Q Wang, Y Zhou, R Wang, J Wang, B Qu, ...
PLoS pathogens 13 (1), e1006156, 2017
|Immunosuppression by mutated calreticulin released from malignant cells|
P Liu, L Zhao, F Loos, C Marty, W Xie, I Martins, S Lachkar, BO Qu, ...
Molecular cell 77 (4), 748-760. e9, 2020
|MicroRNA‐130b Ameliorates Murine Lupus Nephritis Through Targeting the Type I Interferon Pathway on Renal Mesangial Cells|
X Han, Y Wang, X Zhang, Y Qin, B Qu, L Wu, J Ma, Z Zhou, J Qian, M Dai, ...
Arthritis & Rheumatology 68 (9), 2232-2243, 2016
|miRNAs in the pathogenesis of systemic lupus erythematosus|
B Qu, N Shen
International journal of molecular sciences 16 (5), 9557-9572, 2015
|Association of Abnormal Elevations in IFIT 3 with Overactive Cyclic GMP‐AMP Synthase/Stimulator of Interferon Genes Signaling in Human Systemic Lupus Erythematosus Monocytes|
J Wang, M Dai, Y Cui, G Hou, J Deng, X Gao, Z Liao, Y Liu, Y Meng, L Wu, ...
Arthritis & rheumatology 70 (12), 2036-2045, 2018
|Long noncoding RNA profiling revealed differentially expressed lncRNAs associated with disease activity in PBMCs from patients with rheumatoid arthritis|
M Yuan, S Wang, L Yu, B Qu, L Xu, L Liu, H Sun, C Li, Y Shi, H Liu
PLoS One 12 (11), e0186795, 2017
|In vivo therapeutic success of microRNA‐155 antagomir in a mouse model of lupus alveolar hemorrhage|
S Zhou, Y Wang, Y Meng, C Xiao, Z Liu, P Brohawn, BW Higgs, B Jallal, ...
Arthritis & Rheumatology 68 (4), 953-964, 2016
|MiR-125a-5p ameliorates monocrotaline-induced pulmonary arterial hypertension by targeting the TGF-β1 and IL-6/STAT3 signaling pathways|
Z Cai, J Li, Q Zhuang, X Zhang, A Yuan, L Shen, K Kang, B Qu, Y Tang, ...
Experimental & molecular medicine 50 (4), 1-11, 2018
|Identification of renal long non-coding RNA RP11-2B6. 2 as a positive regulator of type I interferon signaling pathway in lupus nephritis|
Z Liao, Z Ye, Z Xue, L Wu, Y Ouyang, C Yao, C Cui, N Xu, J Ma, G Hou, ...
Frontiers in immunology 10, 975, 2019
|miR-744 enhances type I interferon signaling pathway by targeting PTP1B in primary human renal mesangial cells|
X Zhang, X Han, Y Tang, Y Wu, B Qu, N Shen
Scientific reports 5 (1), 1-11, 2015
|Identification of cyclin‐dependent kinase 1 as a novel regulator of type I interferon signaling in systemic lupus erythematosus|
L Wu, Y Qin, S Xia, M Dai, X Han, Y Wu, X Zhang, J Ma, Y Wang, Y Tang, ...
Arthritis & rheumatology 68 (5), 1222-1232, 2016
|Vulnerability of atherosclerotic plaques is associated with type I interferon in a murine model of lupus and atherosclerosis|
CY Zhang, B Qu, P Ye, J Li, CD Bao
Genet Mol Res 14 (4), 14871-14881, 2015